gpn a $40 mill mining company with best part of only $600000 in the bank after YRR injection ,is not a strong cash position going forward?? chairmnan dumping 10 mill options??
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%